Biotechnology company Infinitopes has appointed Jo Brewer as Chief Scientific Officer (CSO) and interim Chief Operating Officer (COO). The company hopes Brewer’s appointment will allow it to advance a therapeutic pipeline of cancer therapies from clinical to commercialisation. With 20 years of experience in advancing therapies from… Read More
Biotechnology company Infinitopes has raised $35.1 million in a seed financing round to accelerate the development of a precision cancer vaccine. The latest finance round was co-led by Octopus Ventures and new investor Amplify Bio, with further participation from new investor Macmillan Cancer Support and existing investors Cancer Research… Read More
Infinitopes presented three posters on its cancer vaccine discovery and development strategy, including one that has been recognised as a ‘top 100’ poster presentation, at the Society for Immunotherapy of Cancer (SITC) 2024, held in Houston, US, from 6-10 November. A spinout from Oxford University, supported by Cancer Research UK (CRUK),… Read More
